Cardiac arrhythmias are frequently seen in patients with dilated cardiomyopathy (DCM) and
can precipitate heart failure and death. In patients with non-ischaemic DCM, evidence for the …

Background: Genotype-phenotype correlations in dilated cardiomyopathy (DCM) and, in
particular, the effects of gene variants on clinical outcomes remain poorly understood …

Dilated cardiomyopathy (DCM) represents one of the primary cardiomyopathies and may
lead to heart failure and sudden death. Until recently, ventricular arrhythmias were …

Background: Genetic analysis is a first-tier test in dilated cardiomyopathy (DCM). Electrical
phenotypes are common in genetic DCM, but their exact contribution to the clinical course …

Nonischemic dilated cardiomyopathy (DCM) often has a genetic pathogenesis. Because of
the large number of genes and alleles attributed to DCM, comprehensive genetic testing …

There is increasing evidence regarding the prevalence of genetic cardiomyopathies, for
which arrhythmias may be the first presentation. Ventricular and atrial arrhythmias …

Background Patients with dilated cardiomyopathy (DCM) may present with ventricular
arrhythmias early in the disease course, unrelated to the severity of left ventricular …

Background Sudden cardiac death due to malignant arrhythmias is a common cause of
death in dilated cardiomyopathy (DCM). Whether genetic variants increase the risk of …

Aims Routine genetic testing in Dilated Cardiomyopathy (DCM) has recently become reality
using Next-Generation Sequencing. Several studies have explored the relationship between …

Dilated cardiomyopathy (DCM) is defined as dilation and/or reduced function of one or both
ventricles and remains a common disease worldwide. An estimated 40% of cases of familial …